Javelin Biotech’s Post

🚀 Elevate Your Knowledge: Join our webinar "Considerations for Navigating ISO 22442-3 Viral Inactivation Studies" Delve into the intricacies of medical devices using preclinical model tissues and their derivatives with NAMSA's experts! Key Discussion Points: - Various applications of preclinical model tissues in medical devices - The critical need for viral inactivation testing - Customizing studies and overcoming associated challenges - Molecular screening and batch release considerations Don't miss out on crucial insights! Save your spot now. 📆👉 https://lnkd.in/emn6wQfN #MedicalDevices #ISO22442 #ViralInactivation #RegulatoryCompliance #NAMSAknows

🚀 Elevate Your Knowledge: Join our webinar "Considerations for Navigating ISO 22442-3 Viral Inactivation Studies" Delve into the intricacies of medical devices using preclinical model tissues and their derivatives with NAMSA's experts! Key Discussion Points: - Various applications of preclinical model tissues in medical devices - The critical need for viral inactivation testing - Customizing studies and overcoming associated challenges - Molecular screening and batch release considerations Don't miss out on crucial insights! Save your spot now. 📆👉https://lnkd.in/emn6wQfN #MedicalDevices #ISO22442 #ViralInactivation #RegulatoryCompliance #NAMSAknows

🚀 Elevate Your Knowledge: Join our webinar "Considerations for Navigating ISO 22442-3 Viral Inactivation Studies" Delve into the intricacies of medical devices using preclinical model tissues and their derivatives with NAMSA's experts! Key Discussion Points: - Various applications of preclinical model tissues in medical devices - The critical need for viral inactivation testing - Customizing studies and overcoming associated challenges - Molecular screening and batch release considerations Don't miss out on crucial insights! Save your spot now. 📆👉https://lnkd.in/emn6wQfN #MedicalDevices #ISO22442 #ViralInactivation #RegulatoryCompliance #NAMSAknows

I invite you to the NAMSA webinar for insights surrounding ISO 22442-3. Bring your questions for the open Q&A session for answers from our industry leading experts - see you there!

🚀 Elevate Your Knowledge: Join our webinar "Considerations for Navigating ISO 22442-3 Viral Inactivation Studies" Delve into the intricacies of medical devices using preclinical model tissues and their derivatives with NAMSA's experts! Key Discussion Points: - Various applications of preclinical model tissues in medical devices - The critical need for viral inactivation testing - Customizing studies and overcoming associated challenges - Molecular screening and batch release considerations Don't miss out on crucial insights! Save your spot now. 📆👉https://lnkd.in/emn6wQfN #MedicalDevices #ISO22442 #ViralInactivation #RegulatoryCompliance #NAMSAknows

🚨 New US patent granted 🚨 We are very happy to share the news that US patent 11,989,882 has been granted by the USPTO 💡 🌎 The patent provides important protection of the novel methods underpinning DoMore Diagnostics’ digital biomarkers and further solidifies our first mover advantage in the rapidly evolving fields of digital pathology and AI-based outcome prediction. For more information, see full PR on our website. #AIinHealthcare #PrecisionMedicine #digitalpathology #DoMore #Patent #IPR https://lnkd.in/dR_VEGcu

🚀 Elevate Your Knowledge: Join our webinar "Considerations for Navigating ISO 22442-3 Viral Inactivation Studies" Delve into the intricacies of medical devices using preclinical model tissues and their derivatives with NAMSA's experts! Key Discussion Points: - Various applications of preclinical model tissues in medical devices - The critical need for viral inactivation testing - Customizing studies and overcoming associated challenges - Molecular screening and batch release considerations Don't miss out on crucial insights! Save your spot now. 📆👉https://lnkd.in/emn6wQfN #MedicalDevices #ISO22442 #ViralInactivation #RegulatoryCompliance #NAMSAknows

🎯 Decision Making Data - Speak to Us At MDC, our imaging platforms can visualise the biodistribution of molecules in cells, tissues and, track novel drug delivery, providing clear evidence of biomarker responses to novel drug candidates. We can access specialist models and PET radiotracers to meet specific programme needs. Helping to advance your programmes with high-quality data.📈 More about how MDC can support your #DrugDiscovery: 🔗 https://hubs.li/Q02qTtQR0 #SMEs #TranslationalImaging #LifeSciences #PreClinicalImaging

Are you navigating the complexities of preclinical and clinical trials? Let’s make it simpler together! Meet us at #ASGCT24, booth 2172, where Accelevir and Noble Life Sciences unite to accelerate your path from discovery to delivery. Dive into our full-service offerings in drug, vaccine, and medical device development, enhanced by precise cell and biomarker analytics. 🧬💡 👋 Swing by for a chat, learn more about our exciting collaboration, and enter our iPad raffle! #baltimore #ASGCT24 #cellandgene

In a recently presented poster entitled: "Real-Time Live Cell Imaging in Successful Antibody-Drug Conjugate Development," Abzena team members discuss the important role that developability assessments play when selecting a lead #ADC drug candidate with the greatest chance of clinical success. Access the poster here: https://lnkd.in/gag2x4tD Abzena poster authors include Campbell Bunce PhD MBA, Robert J Francis PhD FRMS, Grant Harradence,Rob Holgate, Natasha Carter, Erika Kovacs, Nathan Shaw, Adele Kinsey, and Robert Cunningham. #drugdevelopment #bioconjugates #scientificposter